Developer docs
API playgroundTry for free, no card

Search company profiles

Digirad

Full company profile

uuid0038mok

Namestring
Digirad
Legal namestring
Digirad Health, Inc.
Websiteurl
digirad.com
Company typeenum
Public
Founded yearint
1985
Descriptiontext

Digirad Health, Inc. is a US-based medical device manufacturer specializing in solid-state nuclear medicine gamma cameras used for cardiac and general nuclear imaging. Founded in 1985 and headquartered in Suwanee, Georgia, with camera sales and operations in Poway, California, the company operates as a subsidiary of Catalyst MedTech Holdings. Its core technology is built around Cesium Iodide (CsI) pixelated solid-state detector heads, packaged into three primary camera systems: the Cardius X-ACT+ (triple-head SPECT with integrated Fluorescence Attenuation Correction), the Ergo Imaging System (portable, battery-backed general-purpose camera), and the Cardius XPO (dual- or triple-head cardiac SPECT with high-definition solid-state detectors). Proprietary software includes TruACQ count-based imaging and nSPEED 3D-OSEM reconstruction. The company is an FDA-licensed manufacturer with 510(K) cleared devices.

Digirad generates revenue through a hybrid model combining hardware sales, lease, and rental programs for its cameras, plus recurring service contracts (Full Service, Limited Service, Preventative Maintenance, Parts & Support). A distinctive multi-vendor service line provides maintenance for competitor SPECT molecular imaging systems from Philips, GE, Siemens, Sopha/SMV, IS2 Pulse, and Segami, extending recurring service revenue beyond its own installed base. Go-to-market is enterprise field sales with direct phone-based ordering and 'Request More Information' forms on the corporate website, supplemented by a Mobile Imaging Service that removes up-front costs for mid-market customers.

The company targets US hospitals, imaging centers, and veterinary clinics, with clinical applications spanning cardiac SPECT MPI, general nuclear medicine studies, pediatric imaging, surgery/trauma point-of-care imaging, Y90 radioembolization therapy planning, and veterinary nuclear imaging. The firm maintains a nationwide field service engineer organization and holds HITRUST CSF certification alongside FDA 21 CFR Part 820 compliance. Historical growth was driven by acquisitions including Telerhythmics (2014), MD Office Solutions (2015), and DMS Health Technologies (2015, $36M).

Short descriptiontext

Digirad Health, Inc. is a US-based medical device manufacturer that designs and sells solid-state CsI nuclear medicine gamma cameras (Cardius X-ACT+, Ergo, Cardius XPO) for cardiac and general nuclear imaging, serving hospitals, imaging centers, and veterinary clinics via direct sales and recurring service contracts.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersSuwanee, United States
HQ citystring
Suwanee
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
nuclear medicine imaging, gamma cameras, SPECT imaging, medical imaging equipment, diagnostic imaging services
Industry1 code
1Nuclear Medicine & Molecular Imaging (SPECT/PET)
CodeHLAHABAEPrimaryYes
NAICS code2 codes
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
  • Irradiation Apparatus Manufacturing334517
SIC code2 codes
  • X-Ray Apparatus & Tubes & Related Irradiation Apparatus3844
  • Surgical & Medical Instruments & Apparatus3841
Product category
Nuclear Medicine Imaging Equipment
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1Nuclear Camera Hardware Sales
TypeHardware Sales
Description

Direct sale of solid-state nuclear medicine cameras including Cardius X-ACT+, Ergo, and Cardius XPO systems. Traditional purchase with financing available.

digirad.com
2Camera Lease Programs
TypeSubscription Recurring
Description

Flexible lease options for nuclear camera acquisition, providing customers with alternatives to capital purchase.

digirad.com
3Camera Rental
TypeSubscription Recurring
Description

Interim and rental options available for fixed periods, with select cameras available through Mobile Imaging Service with no up-front costs.

digirad.com
4Service Agreements
TypeSubscription Recurring
Description

Comprehensive service contracts including Full Service (98% up-time guarantee, unlimited support), Limited Service, Preventative Maintenance, and Parts & Support options. Revenue from ongoing service contracts.

digirad.com
5Multi-Vendor Service Support
TypeProfessional Services
Description

Service and support for competitor SPECT molecular imaging systems from Philips, GE, Siemens, Sopha/SMV, IS2 Pulse, and Segami. Extends service revenue beyond own product installed base.

digirad.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details4 tiers
1Full Service Agreement
ModelSubscriptionBilling cadenceAnnual
Notes

Comprehensive coverage including 98% up-time guarantee, two Preventative Maintenance visits per year, 100% travel & labor coverage, priority parts with expedited delivery, unlimited remote repair services, unlimited application and technical phone support, and software updates

digirad.com
2Limited Service Agreement
ModelSubscriptionBilling cadenceAnnual
Notes

Essential service solution covering 100% of parts, travel and labor for the first two service visits, two Preventative Maintenance visits per year, unlimited application and technical phone support and software updates

digirad.com
3Preventative Maintenance
ModelSubscriptionBilling cadenceAnnual
Notes

Minimal service solution with factory-trained Service Engineer performing preventative maintenance twice a year

digirad.com
4Parts & Support
ModelSubscriptionBilling cadenceAnnual
Notes

Access to Digirad OEM certified parts, unlimited technical expertise by phone, software updates, with discounted labor and travel rates for additional onsite service

digirad.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Digirad designs, manufactures, and services solid-state nuclear medicine gamma cameras for cardiac and general SPECT imaging used by hospitals and imaging centers. The company complements hardware sales with multi-vendor service programs, preventative maintenance, parts support, and full-service contracts for both its own installed base and competitor SPECT camera systems.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 98% up-time guarantee with Full Service Agreement
+1 more record
Product overview1 text field

Digirad offers a portfolio of solid-state nuclear medicine gamma cameras for cardiology and general nuclear imaging, comprising three main camera product lines (Cardius X-ACT+, Ergo, and Cardius XPO series) along with proprietary software technologies (TruACQ count-based imaging and nSPEED 3D reconstruction), all supported by comprehensive service programs including multi-vendor support for non-Digirad SPECT systems. The cameras utilize CsI solid-state detector technology and are available through purchase, lease, or rental acquisition options.

Product and service1 record
1Cardius X-ACT+
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierParentTypeOthers
Description

Digirad operates as a subsidiary under Catalyst MedTech Holdings. The company logo identifies Digirad as 'A Catalyst MedTech Company', indicating corporate ownership and shared corporate branding.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Philips Healthcare offers BrightView and other SPECT systems used in cardiac and general nuclear medicine that compete directly with Digirad cameras. As one of Digirad's named multi-vendor service partners, Philips is both a direct equipment competitor and a service ecosystem participant.

TypeBroad incumbent
Description

GE Healthcare is a global leader in nuclear medicine imaging, offering the Discovery and Optima SPECT/CT systems that compete head-to-head with Digirad's Cardius series. Its scale, multi-modality portfolio, and worldwide service network make it Digirad's most significant large incumbent competitor.

TypeDirect peer
Description

Dilon Technologies manufactures the Dilon 6800 Gamma Camera, a compact solid-state gamma camera used primarily in molecular breast imaging and general nuclear medicine. Its small-form-factor and solid-state design philosophy mirrors Digirad's Ergo and Cardius cameras, making it a direct niche competitor.

TypeDirect peer
Description

Spectrum Dynamics develops solid-state CZT (cadmium zinc telluride) digital SPECT cameras such as the D-SPECT and VERITON, directly competing with Digirad's solid-state CsI technology. Both companies target the same niche: high-performance solid-state nuclear medicine systems with cardiology and general imaging applications.

TypeBroad incumbent
Description

Canon Medical offers the T-Series and other nuclear medicine imaging systems competing in the same hospital procurement environments as Digirad cameras. Its broader diagnostic imaging portfolio gives it strong bundled-deal leverage in hospital capital sales.

TypeEmerging player
Description

Agiliti is an independent medical equipment service provider that supports multi-vendor imaging equipment including SPECT cameras, directly competing with Digirad's multi-vendor service program. Its growing scale in third-party service represents a competitive threat to one of Digirad's key recurring revenue streams.

TypeDirect peer
Description

Mediso Medical Imaging manufactures SPECT and PET imaging systems used in preclinical and clinical nuclear medicine, overlapping with Digirad's general nuclear medicine camera portfolio. It is an established international player competing for the same category of nuclear imaging equipment customers.

TypeEmerging player
Description

TTI Medical provides service and refurbished nuclear medicine imaging equipment, including support for multiple SPECT camera vendors. Its multi-vendor service model directly overlaps with Digirad's service offering for competitor SPECT systems.

TypeEmerging player
Description

CMR Naviscan specializes in high-resolution molecular breast imaging (MBI) using compact gamma camera technology, overlapping with Digirad's MBI collimator offerings on Cardius cameras. Its breast-imaging specialization positions it as an emerging niche player in a subset of Digirad's addressable use cases.

TypeBroad incumbent
Description

Siemens Healthineers sells Symbia SPECT systems and Symbia Intevo SPECT/CT hybrid systems, directly competing with Digirad's solid-state cameras in cardiac and general nuclear medicine. Its integrated imaging platforms and global installed base make it a formidable broad-spectrum competitor.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Digirad

Nuclear Medicine Imaging Equipmentdigirad.com

Digirad Health, Inc. is a US-based medical device manufacturer that designs and sells solid-state CsI nuclear medicine gamma cameras (Cardius X-ACT+, Ergo, Cardius XPO) for cardiac and general nuclear imaging, serving hospitals, imaging centers, and veterinary clinics via direct sales and recurring service contracts.

What Digirad does

Digirad Health, Inc. is a US-based medical device manufacturer specializing in solid-state nuclear medicine gamma cameras used for cardiac and general nuclear imaging. Founded in 1985 and headquartered in Suwanee, Georgia, with camera sales and operations in Poway, California, the company operates as a subsidiary of Catalyst MedTech Holdings. Its core technology is built around Cesium Iodide (CsI) pixelated solid-state detector heads, packaged into three primary camera systems: the Cardius X-ACT+ (triple-head SPECT with integrated Fluorescence Attenuation Correction), the Ergo Imaging System (portable, battery-backed general-purpose camera), and the Cardius XPO (dual- or triple-head cardiac SPECT with high-definition solid-state detectors). Proprietary software includes TruACQ count-based imaging and nSPEED 3D-OSEM reconstruction. The company is an FDA-licensed manufacturer with 510(K) cleared devices.

Digirad generates revenue through a hybrid model combining hardware sales, lease, and rental programs for its cameras, plus recurring service contracts (Full Service, Limited Service, Preventative Maintenance, Parts & Support). A distinctive multi-vendor service line provides maintenance for competitor SPECT molecular imaging systems from Philips, GE, Siemens, Sopha/SMV, IS2 Pulse, and Segami, extending recurring service revenue beyond its own installed base. Go-to-market is enterprise field sales with direct phone-based ordering and 'Request More Information' forms on the corporate website, supplemented by a Mobile Imaging Service that removes up-front costs for mid-market customers.

The company targets US hospitals, imaging centers, and veterinary clinics, with clinical applications spanning cardiac SPECT MPI, general nuclear medicine studies, pediatric imaging, surgery/trauma point-of-care imaging, Y90 radioembolization therapy planning, and veterinary nuclear imaging. The firm maintains a nationwide field service engineer organization and holds HITRUST CSF certification alongside FDA 21 CFR Part 820 compliance. Historical growth was driven by acquisitions including Telerhythmics (2014), MD Office Solutions (2015), and DMS Health Technologies (2015, $36M).

Digirad firmographics

Firmographics
Name
Digirad
Legal name
Digirad Health, Inc.
Website
https://digirad.com
Company type
Public
Founded year
1985
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Digirad Health, Inc. is a US-based medical device manufacturer that designs and sells solid-state CsI nuclear medicine gamma cameras (Cardius X-ACT+, Ergo, Cardius XPO) for cardiac and general nuclear imaging, serving hospitals, imaging centers, and veterinary clinics via direct sales and recurring service contracts.
Ownership category
akta.pro rank

Digirad industry classification

Industry
Product category
Nuclear Medicine Imaging Equipment
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Irradiation Apparatus Manufacturing (334517)
SIC
X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Nuclear Medicine & Molecular Imaging (SPECT/PET) (HLAHABAE)

Keywords

  • Nuclear medicine imaging
  • Gamma cameras
  • SPECT imaging
  • Medical imaging equipment
  • Diagnostic imaging services

Where Digirad is headquartered

Location

Headquarters

HQ city
Suwanee
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Digirad business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Nuclear Camera Hardware Sales: Direct sale of solid-state nuclear medicine cameras including Cardius X-ACT+, Ergo, and Cardius XPO systems. Traditional purchase with financing available.
  2. Camera Lease Programs: Flexible lease options for nuclear camera acquisition, providing customers with alternatives to capital purchase.
  3. Camera Rental: Interim and rental options available for fixed periods, with select cameras available through Mobile Imaging Service with no up-front costs.
  4. Service Agreements: Comprehensive service contracts including Full Service (98% up-time guarantee, unlimited support), Limited Service, Preventative Maintenance, and Parts & Support options. Revenue from ongoing service contracts.
  5. Multi-Vendor Service Support: Service and support for competitor SPECT molecular imaging systems from Philips, GE, Siemens, Sopha/SMV, IS2 Pulse, and Segami. Extends service revenue beyond own product installed base.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualFull Service Agreement
SubscriptionAnnualLimited Service Agreement
SubscriptionAnnualPreventative Maintenance
SubscriptionAnnualParts & Support

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Digirad product offering

Product offering

Core offering

Digirad designs, manufactures, and services solid-state nuclear medicine gamma cameras for cardiac and general SPECT imaging used by hospitals and imaging centers. The company complements hardware sales with multi-vendor service programs, preventative maintenance, parts support, and full-service contracts for both its own installed base and competitor SPECT camera systems.

Product overview

Digirad offers a portfolio of solid-state nuclear medicine gamma cameras for cardiology and general nuclear imaging, comprising three main camera product lines (Cardius X-ACT+, Ergo, and Cardius XPO series) along with proprietary software technologies (TruACQ count-based imaging and nSPEED 3D reconstruction), all supported by comprehensive service programs including multi-vendor support for non-Digirad SPECT systems. The cameras utilize CsI solid-state detector technology and are available through purchase, lease, or rental acquisition options.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cardius X-ACT+

Quantifiable outcome

  • 98% up-time guarantee with Full Service Agreement
  • +1 more outcomes

Companies that use Digirad

Customer profile

Segments6 records

Ideal customer profiles3 records

Digirad technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Digirad partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Catalyst MedTechparentOthersDigirad operates as a subsidiary under Catalyst MedTech Holdings. The company logo identifies Digirad as 'A Catalyst MedTech Company', indicating corporate ownership and shared corporate branding.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Digirad competitors and assessment

Company assessment

Broad incumbents

  • Philips: Philips Healthcare offers BrightView and other SPECT systems used in cardiac and general nuclear medicine that compete directly with Digirad cameras. As one of Digirad's named multi-vendor service partners, Philips is both a direct equipment competitor and a service ecosystem participant.
  • GE Healthcare: GE Healthcare is a global leader in nuclear medicine imaging, offering the Discovery and Optima SPECT/CT systems that compete head-to-head with Digirad's Cardius series. Its scale, multi-modality portfolio, and worldwide service network make it Digirad's most significant large incumbent competitor.
  • Canon Medical Systems (formerly Toshiba Medical): Canon Medical offers the T-Series and other nuclear medicine imaging systems competing in the same hospital procurement environments as Digirad cameras. Its broader diagnostic imaging portfolio gives it strong bundled-deal leverage in hospital capital sales.
  • Siemens Healthineers: Siemens Healthineers sells Symbia SPECT systems and Symbia Intevo SPECT/CT hybrid systems, directly competing with Digirad's solid-state cameras in cardiac and general nuclear medicine. Its integrated imaging platforms and global installed base make it a formidable broad-spectrum competitor.

Direct peers

  • Dilon Technologies: Dilon Technologies manufactures the Dilon 6800 Gamma Camera, a compact solid-state gamma camera used primarily in molecular breast imaging and general nuclear medicine. Its small-form-factor and solid-state design philosophy mirrors Digirad's Ergo and Cardius cameras, making it a direct niche competitor.
  • Spectrum Dynamics Medical: Spectrum Dynamics develops solid-state CZT (cadmium zinc telluride) digital SPECT cameras such as the D-SPECT and VERITON, directly competing with Digirad's solid-state CsI technology. Both companies target the same niche: high-performance solid-state nuclear medicine systems with cardiology and general imaging applications.
  • Mediso Medical Imaging Systems: Mediso Medical Imaging manufactures SPECT and PET imaging systems used in preclinical and clinical nuclear medicine, overlapping with Digirad's general nuclear medicine camera portfolio. It is an established international player competing for the same category of nuclear imaging equipment customers.

Emerging players

  • Agiliti: Agiliti is an independent medical equipment service provider that supports multi-vendor imaging equipment including SPECT cameras, directly competing with Digirad's multi-vendor service program. Its growing scale in third-party service represents a competitive threat to one of Digirad's key recurring revenue streams.
  • TTI Medical: TTI Medical provides service and refurbished nuclear medicine imaging equipment, including support for multiple SPECT camera vendors. Its multi-vendor service model directly overlaps with Digirad's service offering for competitor SPECT systems.
  • CMR Naviscan: CMR Naviscan specializes in high-resolution molecular breast imaging (MBI) using compact gamma camera technology, overlapping with Digirad's MBI collimator offerings on Cardius cameras. Its breast-imaging specialization positions it as an emerging niche player in a subset of Digirad's addressable use cases.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Digirad social profiles

Digital presence

Digirad compliance and trust

Trust signal

Compliance2 records

Digirad financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Digirad leadership team

Management profile

Number of profiles

Profiles4 records

Digirad funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Digirad M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Digirad

What does Digirad do?

Digirad designs, manufactures, and services solid-state nuclear medicine gamma cameras for cardiac and general SPECT imaging used by hospitals and imaging centers. The company complements hardware sales with multi-vendor service programs, preventative maintenance, parts support, and full-service contracts for both its own installed base and competitor SPECT camera systems.

Is Digirad a public or private company?

Digirad is a public company. It is classified as corporate owned and is currently operating.

When was Digirad founded?

Digirad was founded in 1985. It employs 501 to 1,000 people.

Where is Digirad based?

Digirad is headquartered in Suwanee, United States, in the North America region.

How does Digirad make money?

Five revenue lines are on record. Nuclear Camera Hardware Sales are the primary driver. The others are camera Lease Programs, camera Rental, service Agreements and multi-Vendor Service Support.

Who are Digirad's main competitors?

Broad incumbents on record are Philips, GE Healthcare, Canon Medical Systems (formerly Toshiba Medical) and Siemens Healthineers. Direct peers are Dilon Technologies, Spectrum Dynamics Medical and Mediso Medical Imaging Systems. Emerging players are Agiliti, TTI Medical and CMR Naviscan.

Does Digirad have an API?

No public API is recorded for Digirad.

What industry is Digirad in?

Digirad's product category is Nuclear Medicine Imaging Equipment. Its primary akta.pro industry code is HLAHABAE, Nuclear Medicine & Molecular Imaging (SPECT/PET). Its NAICS code is 33451 and its SIC code is 3844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinSMEsTTG Imaging Solutions Buys Digirad Health from Star Equity HoldingsTTG Imaging Solutions has acquired Digirad Health from Star Equity Holdings to expand its service offerings in cardiology and radiation oncology markets. The financial terms of the transaction were not disclosed, but the deal allows TTG to broaden its portfolio of fixed and mobile nuclear medicine camera solutions.GlobeNewswireStar Equity Holdings, Inc. Announces Sale of Digirad Health, Inc. for $40 MillionStar Equity Holdings completed the sale of Digirad Health to TTG Imaging Solutions for $40 million on May 4, 2023. The consideration includes $27 million cash, a $7 million promissory note, and $6 million of TTG equity. Star Equity will retain an equity stake and pursue further acquisitions.PR NewswireTTG Imaging Solutions Acquires Digirad Health from Star Equity HoldingsTTG Imaging Solutions completed the acquisition of Digirad Health from Star Equity Holdings on May 4, 2023. The transaction expands TTG's service footprint and headcount to over 80 individuals, integrating Digirad's OEM camera manufacturing capabilities with TTG's existing imaging services. This move aims to create a leading full-service platform for cardiology and radiation oncology markets.BioSpaceTTG Imaging Solutions Acquires Digirad Health from Star Equity HoldingsTTG Imaging Solutions completed the acquisition of Digirad Health from Star Equity Holdings on May 4, 2023. This transaction expands TTG's nationwide field service team to over 80 individuals and integrates Digirad's OEM capabilities into TTG's existing cardiology and radiation oncology service offerings.GlobeNewswireDigirad Corporation Changes Corporate Name to Star Equity Holdings, Inc.Digirad Corporation changed its corporate name to Star Equity Holdings, effective January 1, 2021, with stock trading under the new ticker STRR. The healthcare division retains its Digirad brand, while the building division becomes Star Building & Construction. The company plans to use proceeds from a $18.75 million sale of its mobile healthcare business to fund growth investments.GlobeNewswireDigirad Corporation to Present at Investor Conferences in NovemberDigirad Corporation announced its management will participate in two virtual investor conferences on November 17 and 18. The company, a diversified holding company with healthcare, construction, and real estate divisions, will host meetings and provide a presentation PDF.GlobeNewswireDigirad Corporation Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2020Digirad reported Q3 2020 revenue of $30.4 million, up 7.1% year-over-year, but a net loss of $1.8 million. Nine-month revenue rose 4.5% to $81.6 million, while net loss widened to $6.0 million. The company also entered a stock purchase agreement to sell its DMS Health business unit for $18.75 million, expected to close in January 2021.BenzingaWhy Digirad's Stock Is Trading Higher TodayDigirad announced the sale of its DMS Health Technologies business unit for $18.75 million, causing shares to trade higher by 3.14% to $23.14 on Wednesday. The diversified holding company operates three divisions: Healthcare, Building & Construction, and Real Estate & Investments. The stock has a 52-week high of $8.84 and a 52-week low of $1.99.Benzinga5 Stocks To Watch For November 4, 2020 - MetLife (NYSE:MET)The article outlines five stocks to watch on November 4, 2020, detailing recent market movements and upcoming earnings reports for Performance Food Group, Super Micro Computer, QUALCOMM, Digirad Corporation, and MetLife. Key developments include Super Micro Computer's better-than-expected results and $50 million buyback plan, and Digirad Corporation's agreement to sell its DMS Health Technologies business unit for $18.75 million.PR NewswireThinking about buying stock in Bank of America, Digirad Corp, Advanced Micro Devices, Tesla, or AbbVie?InvestorsObserver issued PriceWatch Alerts for Bank of America, Digirad Corp, Advanced Micro Devices, Tesla, and AbbVie based on its proprietary scoring methodology. The alerts evaluate these stocks using short-term technical, long-term technical, and fundamental factors to determine investment suitability.